OPOS, with the slogan "Quality of Life is the Health Outcome," specializes in chronic pain management and opioid therapy. Founded in 2017 by a team of healthcare providers, data scientists, IT experts, and business professionals, OPOS leverages over 20 years of experience in treating chronic pain patients. The company focuses on ensuring compliance with Medical Board regulations and CDC guidelines to provide access to opioid therapies for chronic pain patients, ultimately maximizing their function, productivity, and quality of life. OPOS recently received a $247.56K grant investment from the National Science Foundation on 26th November 2021. With its innovative solutions and network of board-certified pain specialists, OPOS aims to transform chronic pain care, making a significant impact in the health care industry. For more information, visit https://opos.solutions.
General Information
Get notified when OPOS moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Discover More
United States Market
Health Care
About OPOS
Taxonomy: Chronic pain management, Opioid therapy, Regulatory compliance, Digital therapeutics, Telemedicine, Healthcare services, Pain specialists, Medical board compliance, Healthcare innovation, Patient care, Quality of life improvement
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | •••••• | 1 |
|
26 Nov 2021 |
OPOS Alternatives & Competitors
Pioneering Non-Opioid Analgesic Gene Therapies for Chronic Pain
PE Backed National Interventional Pain Management Services Company.
Semnur Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the clinical and comme...
FAQ About OPOS
Don't just browse. Track.
Signal Tracker monitors OPOS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.